The objective of the study is to evaluate the efficacy of monitoring after discharge of patients with high-risk acute coronary syndrome.
The objective of the study is to evaluate the efficacy of monitoring after discharge of patients with high-risk acute coronary syndrome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
169
Implantable cardiac monitor and Smart-phone based electrocardiogram recording
No intervention
Hospital Universitario Marques de Valdecilla
Santander, Spain
Atrial fibrilation (AF / atrial flutter)
Detection rates for atrial fibrilation (AF / atrial flutter) during the follow up.
Time frame: 1 year
Ventricular arrhythmia in the electrocardiogram (EKG)
Detection rates of ventricular arrhythmia in the electrocardiogram (EKG) during the follow up.
Time frame: 1 year
Advanced conduction abnormalities and significant ST shifts (> 1 mm) in the EKG
Detection rates of advanced conduction abnormalities and significant ST shifts (\> 1 mm) in the EKG.
Time frame: 1 year
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
MACCE rates defined as cardiovascular and cerebrovascular events during the follow up.
Time frame: 1 year
Re-hospitalization
Number of Re-hospitalization during the follow up.
Time frame: 1 year
Correlation of primary outcomes between Biomonitor-2 versus Kardia Mobile
Correlation of primary outcomes between Biomonitor-2 versus Kardia Mobile during the follow up.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.